Pasithea shares surge 11.06% intraday after regaining Nasdaq minimum bid price compliance ahead of deadline.

lunes, 15 de diciembre de 2025, 2:35 pm ET1 min de lectura
KTTA--
Pasithea Therapeutics surged 11.06% intraday after announcing it regained Nasdaq compliance with.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios